Open AccessThe fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by fixed dose combinations of AT1 receptor antagonists and low dose HCTZ
Author(s) -
R. Fuenfstueck,
Roelie Hempel,
A ANSARI,
G WEIDINGER,
Sven Klebs
Publication year - 2005
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2005.03.162
Subject(s) - fixed dose combination , valsartan , medicine , angiotensin ii receptor type 1 , pharmacology , hydrochlorothiazide , urology , combination therapy , angiotensin ii , blood pressure
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom